Navigation Links
Isis Reports Financial Results and Highlights for Second Quarter 2013
Date:8/6/2013

c and diluted net loss per share for the three and six months ended June 30, 2013 was $0.09 per share and $0.11 per share, respectively, compared to $0.01 per share and $0.25 per share for the same periods in 2012. Isis' net loss for the six months ended June 30, 2013 was significantly lower than in 2012 primarily due to the revenue Isis earned from its partners in the first half of 2013.

Balance Sheet
As of June 30, 2013, Isis had cash, cash equivalents and short-term investments of $590.8 million compared to $374.4 million at December 31, 2012 and working capital of $582.1 million at June 30, 2013 compared to $349.1 million at December 31, 2012.  The Company received a substantial amount of cash in the first six months of 2013, including $210 million from the issuance of its common stock and $93 million in payments from its partners.  Isis' working capital increased in 2013 primarily due to the increase in cash and the increase in the value of Isis' ownership in Regulus.  At June 30, 2013, the carrying value of Isis' investment in Regulus increased to $62.2 million compared to $33.6 million at December 31, 2012.  This increase demonstrates the value that Isis is realizing from its satellite company strategy.

Business Highlights
"Our innovative business strategy provides us with multiple opportunities to create and maintain value.  We design our drug development activities to demonstrate the broad therapeutic profile of each drug.  In this way, we strive to maximize the value of each drug.  For example, ISIS-APOCIIIRx is an antisense drug we discovered and are developing to treat patients with severely high triglycerides.  Because of our clinical experience with KYNAMRO, our strong internal development capabilities and the manageable size of the clinical program required for our initial indication, we believe we can successfully develop ISIS-APOCIIIRx on our own without a partn
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. CVS Caremark Reports Record Second Quarter Results
2. BioLineRx Reports Second Quarter 2013 Results
3. Regeneron Reports Second Quarter 2013 Financial and Operating Results
4. Cytos Biotechnology Ltd Reports Second Quarter 2013 Financial Results and Recent Developments
5. Volcano Reports Second Quarter Results; Medical Segment Revenues Increase More Than 13 Percent On A Constant Currency Basis
6. Landauer, Inc. Reports Fiscal 2013 Third Quarter Results
7. PDI Reports 2013 Second Quarter Financial Results
8. U.S. Orthopedic Biomaterials Market & Global Biomaterials Industry Reviewed by Products and Applications in New Research Reports
9. Isis Pharmaceuticals Reports Data From a Phase 2 Study of Isis-CRP Rx in Patients with Rheumatoid Arthritis
10. GW Pharmaceuticals plc Reports 2013 Third Quarter Financial Results
11. Neuland Labs Reports First Quarter Fiscal Year 2014 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... July 2, 2015 Roche,s Bloodhound technology ... market segment in hematology testing, according to Kalorama ... recent unveiling of its Bloodhound digital cell imaging ... m 511 hematology analyzer – is notable ... enjoyed by current leader CellaVision, but also compete ...
(Date:7/2/2015)... Texas , July 2, 2015   EVO ... being the leading provider for non-invasive aesthetics in ... state-of-the-art tattoo removal treatments with the Astanza Duality laser. ... their well being through various medical and laser procedures. ... with unwanted ink a clear solution to their tattoo ...
(Date:7/2/2015)... , July 2, 2015   Decision ... European retinal specialists identify less frequent dosing as ... (DME), due to the burden on both patients ... endothelial growth factor (VEGF) injections, which are the ... Partners, abicipar pegol, which is in development for ...
Breaking Medicine Technology:Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3EVO Offers Advanced Laser Tattoo Removal With Astanza Duality In Lakeway, TX 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 3
... WORTH, Texas, April 20, 2011 Wound Management Technologies, Inc., ... solutions, today released a letter from its president, Deborah Jenkins ... the company. April 20, 2011 ... inform you that our Company has entered an exciting new ...
... Calif., April 20, 2011 DC Electronics, a San Jose, ... expansion of its 30,000 sq.ft. facility in San Jose, CA. ...   "We want to stay ahead of our ... kind of company that can do that," says VP of ...
Cached Medicine Technology:Wound Management Technologies President Writes Letter to Its Shareholders; Cites 3x Revenues Increase Over 2009; CellerateRX® Gaining Traction 2Wound Management Technologies President Writes Letter to Its Shareholders; Cites 3x Revenues Increase Over 2009; CellerateRX® Gaining Traction 3Wound Management Technologies President Writes Letter to Its Shareholders; Cites 3x Revenues Increase Over 2009; CellerateRX® Gaining Traction 4Wound Management Technologies President Writes Letter to Its Shareholders; Cites 3x Revenues Increase Over 2009; CellerateRX® Gaining Traction 5Wound Management Technologies President Writes Letter to Its Shareholders; Cites 3x Revenues Increase Over 2009; CellerateRX® Gaining Traction 6Wound Management Technologies President Writes Letter to Its Shareholders; Cites 3x Revenues Increase Over 2009; CellerateRX® Gaining Traction 7Wound Management Technologies President Writes Letter to Its Shareholders; Cites 3x Revenues Increase Over 2009; CellerateRX® Gaining Traction 8DC Electronics Expands Facilities to Increase Capacity 2
(Date:7/2/2015)... VA (PRWEB) , ... July 02, 2015 , ... ... Congresswoman Donna Edwards (D-Md.) for her introduction of the Stop Overdose Stat (S.O.S.) ... introduced by Senator Jack Reed (D-R.I.), this Act seeks to decrease drug overdose ...
(Date:7/2/2015)... ... July 02, 2015 , ... In 2012, Patrick Achebe realized that the gift of poetry ... sat down to write his first poem, and three years later he was publishing an ... and worth sharing with the world. "I have always believed that the best way to ...
(Date:7/2/2015)... CITY, GA (PRWEB) , ... July 02, 2015 , ... ... their newest innovation in compression socks designed for men. , For style that’s ... socks into their daily routine. This is great news for men everywhere because a ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... and Emerging Healthcare Delivery Coalition met for the late June Web-based session, the ... with new reimbursement schemes and managing high-risk patients through coordinated care. , During ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... and executing them with care and precision. There is an art and science ... had the honor of successfully reshaping the facial features and lives of more ...
Breaking Medicine News(10 mins):Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 4Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3
... MONDAY, March 7 (HealthDay News) -- Genetics may predispose some ... and stress are a fact of daily life -- to ... warns. The culprit is a specific abnormality of the ... gene is known to play a key role in the ...
... March 7, 2011 Embargoed by the journal ... time Working as part of a public program to ... useful molecules, scientists from The Scripps Research Institute and ... potent class of potential anti-cancer and anti-neurodegenerative disorder compounds. ...
... it won,t be obvious to UCSF Medical Center patients, behind ... processes their medications. With a new automated hospital pharmacy, believed ... technology and electronics to prepare and track medications with the ... error has occurred in the 350,000 doses of medication prepared ...
... of recognizing tumor growth, and naturally mounts an anti-cancer ... (antigens) and present them to T cells, and those ... kill tumor cells. In recent years, researchers have attempted ... new therapies- namely, by generating a pool of tumor ...
... Transplanting stem cells derived from umbilical ... offer future therapeutic benefit for those suffering from ... says a team of neuroscience researchers from the ... Brain Repair and collaborators from three private-sector research ...
... Reinberg HealthDay Reporter , SUNDAY, March 6 (HealthDay ... a safe way to detect Down syndrome during pregnancy, researchers ... identified a gene mutation associated with Down syndrome with 100 ... is a common birth defect, with one Down syndrome birth ...
Cached Medicine News:Health News:Mix of Genetics and Stress Can Impair Mental Abilities 2Health News:Scripps Research and MIT scientists discover class of potent anti-cancer compounds 2Health News:Scripps Research and MIT scientists discover class of potent anti-cancer compounds 3Health News:Scripps Research and MIT scientists discover class of potent anti-cancer compounds 4Health News:New UCSF robotic pharmacy aims to improve patient safety 2Health News:New UCSF robotic pharmacy aims to improve patient safety 3Health News:Transplanting umbilical cord and menstrual blood-derived stem cells offer hope for disorders 2Health News:Transplanting umbilical cord and menstrual blood-derived stem cells offer hope for disorders 3Health News:Transplanting umbilical cord and menstrual blood-derived stem cells offer hope for disorders 4Health News:Noninvasive Test May Identify Down Syndrome Early On 2
... Tissue Oximeter is a lightweight, portable console display ... with two separate channels for up to one ... well as adjustable alarms for low and high ... very user friendly and requires minimal training., ,Sensors ...
CO 2 SMO-Capnograph/Pulse Oximeter...
... the next generation in pulse oximetry monitoring ... current family of "digital pulse oximeters, MARSpO ... breakthroughs in signal processing. This provides improved ... superior performance during challenging clinical conditions such ...
... Pulse Oximeter is a one-of-a-kind oximeter that ... the N-20PA has been shock-tested, vibration-tested and ... it has even withstood the rigors of ... spot check measurements and also useful for ...
Medicine Products: